Hakan Öztürk

Hakan Öztürk

Auto-generated profile, based on publicly available information

Hakan Öztürk


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2025 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
NKNeslihan Gürcan Kaya
Neslihan Gürcan Kaya
HÖHakan Öztürk
Hakan Öztürk
SSSinan Sari
Sinan Sari
OGOdul Egritas Gurkan
Odul Egritas Gurkan
BDBuket Dalgıç
Buket Dalgıç

2 June 2003 in Clinical Anatomy
Verified
Journal Article
Closed access
PDF file
ABAlp Bayramoǧlu
Alp Bayramoǧlu
UAUstun Aydingoz
Ustun Aydingoz
MHMutlu Hayran
Mutlu Hayran
HÖHakan Öztürk
Hakan Öztürk
MCMeserret Cumhur
Meserret Cumhur

1 January 2019 in Experimental and Clinical Transplantation
Verified
Journal Article
Closed access
HÖHakan Öztürk
Hakan Öztürk
NBNeslihan Ekşi Bozbulut
Neslihan Ekşi Bozbulut
SSSinan Sarı
Sinan Sarı
OGOdul Egritas Gurkan
Odul Egritas Gurkan
HSHakan Sözen
Hakan Sözen
BDBuket Dalgıç
Buket Dalgıç
Objectives: Our aim was to determine potentially adverse effects of immunosuppressive protocols after liver transplantation in children. Materials and Methods: The medical records of 60 children who underwent liver transplant retrospectively analyzed. Corticosteroid, tacrolimus, and mycophenolate mofetil were the primary immunosuppressive agents used in our center. Results: The mean age of children was 6.1 years, ranging from 3 months to 17 years (34 boys, 26 girls). The most common indication for liver transplant was biliary atresia (26.7%). Thirty-nine patients (65%) received livers from living donors, and 21 patients (35%) received from livers from deceased donors. The main complications of immunosuppressive therapy were diarrhea associated with mycophenolate mofetil, hyperglycemia and hypertension associated with corticosteroid, and seizures and tremors associated with tacrolimus. Two patients developed posttransplant lymphoproliferative disorder. The diagnosis was based on histologic findings of cervical lymphadenopathy and duodenal biopsy. One patient was diagnosed with acute lymphoblastic lymphoma. In addition to these predictable adverse effects, unusual adverse effects of immunosuppression were also observed. Hemolytic anemia (n = 3) (one was also diagnosed with Evans syndrome), eosinophilic gastroenteritis (n = 2), de novo food allergy (n = 2), posttransplant lymphoproliferative disorder (n = 2), Burkitt lymphoma (n = 1), and renal tubular acidosis (n =1) were thought to be related to tacrolimus therapy. Conclusions: Adverse effects of immunosuppression represent a major cause of postoperative morbidity. The common effects of immunosuppression are recognized easily by clinicians. It should be kept in mind that unexpected symptoms and signs may be related to immunosuppression in pediatric liver transplant patients.

15 March 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
OGOdul Egritas Gurkan
Odul Egritas Gurkan
HÖHakan Öztürk
Hakan Öztürk
CKCEM KAYA
CEM KAYA
NKNeslihan Gürcan Kaya
Neslihan Gürcan Kaya
NBNeslihan Ekşi Bozbulut
Neslihan Ekşi Bozbulut
KSKaan Sönmez
Kaan Sönmez
Background/Aims: Gastric outlet obstruction (GOO) is a rare condition in childhood, with the exception of infantile hypertrophic pyloric stenosis (IHPS). However, no classification exists from a pediatric gastroenterologists perspective. Materials and Methods: The patients with a diagnosis of GOO between 2009 and 2020 were reviewed retrospectively. We classified the patients according to GOO: presence of clinical findings accompanied by radiological and/or endoscopic findings; clinical status: intractable nonbilious postprandial vomiting alone or with abdominal pain, early satiety, weight loss, postprandial abdominal distension, and malnutrition; radiology: delayed gastric emptying and dilated stomach; endoscopy: nonbilious gastric contents after 6-8 hours of emptying and/or failed pyloric intubation; physical examination: visible gastric peristalsis. Results: A total of 30 GOO patients (15 patients with IHPS, 1 patient with annular pancreas, 4 patients with gastric volvulus, 2 patients with duodenal atresia, 2 patients with antral web, 1 patient with late-onset hypertrophic pyloric stenosis (LHPS) had surgical treatment, and remaining 5 patients had medical treatment) were enrolled to the study. The median age was 8 months (range: 3 months-16 years), and 14 patients were female. Mitochondrial disorders, LHPS, metabolic disorders, and eosinophilic gastrointestinal system diseases were added to Sharmas GOO classification, and the classification has been expanded. Conclusion: This is the first and largest study of GOO in children. From the perspective of pediatric gastroenterology, new diseases will be addressed, and definitions will be highlighted with our classification for GOO in childhood. Cite this article as: Eğritaş Grkan ö, öztrk H, Kaya C, et al. A classification for gastric outlet obstruction in childhood: Extending beyond infantile hypertrophic pyloric stenosis. Turk J Gastroenterol. 2024;35(3):255-261.

15 September 2023 in Trends in Pediatrics
Verified
Journal Article
Open access
ÜAÜmmüşen Kaya Akca
Ümmüşen Kaya Akca
SBSavas Baris
Savas Baris
HÖHakan Öztürk
Hakan Öztürk
Objective: Poor adherence to medications is an important problem, especially in patients with chronic diseases such as familial Mediterranean fever (FMF). In this study, we aimed to evaluate medication adherence in pediatric FMF patients and investigate the relationship between disease perception and treatment compliance. Method: Pediatric patients (60), while 44% of the patients were non-adherent to the treatment. Patients aged under 12 years of age were more adherent to colchicine treatment than those over 12 years of age (68.2% vs. 25.0%, p= 0.002). The comparison of the illness perception and medication adherence revealed higher brief IPQ total scores in patients who adhered to the treatment (median 48.5 vs 52.5, p=0.037). We found significant differences in timeline scores between patients who were adherent and those who were non-adherent to the treatment (p=0.01). Conclusion: Non-adherence to medication is an important and widespread problem, particularly among adolescent patients. Perceptions of the illness and beliefs about the duration of the disease may affect adherence to treatment. Medication adherence should be routinely assessed at follow-up visits and educational interventions might improve adherence to the treatment.

10 May 2013 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
DUDeniz Uzmansel
Deniz Uzmansel
NONail Can Ozturk
Nail Can Ozturk
AKAlev Kara
Alev Kara
HOHakan Ozturk
Hakan Ozturk